X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9605) 9605
Publication (600) 600
Book Review (266) 266
Book Chapter (144) 144
Newsletter (84) 84
Book / eBook (51) 51
Conference Proceeding (22) 22
Magazine Article (11) 11
Newspaper Article (8) 8
Web Resource (3) 3
Dissertation (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7770) 7770
female (4795) 4795
index medicus (3961) 3961
adult (3443) 3443
male (3251) 3251
systemic lupus erythematosus (3244) 3244
rheumatology (3134) 3134
middle aged (2676) 2676
lupus erythematosus, systemic - complications (2566) 2566
lupus (1925) 1925
systemic-lupus-erythematosus (1741) 1741
vasculitis (1415) 1415
aged (1408) 1408
adolescent (1279) 1279
disease (1093) 1093
immunology (1082) 1082
risk factors (1022) 1022
medicine & public health (946) 946
systemic vasculitis (905) 905
diagnosis (846) 846
treatment outcome (823) 823
child (805) 805
lupus erythematosus, systemic - diagnosis (766) 766
autoimmune diseases (762) 762
lupus erythematosus, systemic - immunology (758) 758
lupus erythematosus, systemic - drug therapy (734) 734
immunosuppressive agents - therapeutic use (729) 729
retrospective studies (723) 723
care and treatment (721) 721
diagnosis, differential (720) 720
autoantibodies (702) 702
antibodies (671) 671
rheumatoid-arthritis (668) 668
prognosis (636) 636
medicine, general & internal (634) 634
classification (630) 630
young adult (623) 623
animals (605) 605
autoimmunity (579) 579
arthritis (576) 576
scleroderma (565) 565
lupus erythematosus, systemic - pathology (554) 554
research (528) 528
systemic lupus-erythematosus (526) 526
health aspects (522) 522
prevalence (520) 520
antiphospholipid syndrome (508) 508
therapy (507) 507
rheumatoid arthritis (489) 489
nephritis (486) 486
inflammation (485) 485
vasculitis - complications (481) 481
mortality (480) 480
patients (475) 475
biopsy (473) 473
internal medicine (442) 442
severity of illness index (441) 441
dermatology (437) 437
pregnancy (420) 420
magnetic resonance imaging (409) 409
manifestations (406) 406
analysis (404) 404
cyclophosphamide (402) 402
antiphospholipid antibodies (398) 398
complications and side effects (392) 392
rituximab (390) 390
pediatrics (387) 387
sle (387) 387
urology & nephrology (384) 384
follow-up studies (378) 378
lupus erythematosus, systemic - physiopathology (377) 377
aged, 80 and over (374) 374
systemic sclerosis (365) 365
scleroderma, systemic - complications (360) 360
children (357) 357
erythematosus (348) 348
abridged index medicus (344) 344
association (344) 344
development and progression (344) 344
pathogenesis (342) 342
anticardiolipin antibodies (340) 340
systemic scleroderma (338) 338
wegeners-granulomatosis (336) 336
case-control studies (335) 335
corticosteroids (335) 335
thrombosis (333) 333
medical research (330) 330
vasculitis - etiology (319) 319
disease-activity (318) 318
skin and connective tissue diseases (317) 317
immunoglobulins (313) 313
clinical neurology (308) 308
autoimmune diseases - immunology (307) 307
child, preschool (304) 304
medicine (304) 304
cyclophosphamide - therapeutic use (303) 303
lupus erythematosus, systemic - therapy (303) 303
glucocorticoids - therapeutic use (300) 300
risk-factors (299) 299
pathology (296) 296
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (36) 36
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
St. Michael's Hospital - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Holland Reference (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9334) 9334
French (159) 159
German (87) 87
Japanese (76) 76
Spanish (74) 74
Russian (49) 49
Polish (26) 26
Portuguese (18) 18
Italian (15) 15
Korean (11) 11
Chinese (9) 9
Hungarian (7) 7
Romanian (6) 6
Dutch (5) 5
Turkish (4) 4
Czech (3) 3
Arabic (2) 2
Serbian (2) 2
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2010, Volume 69, Issue 6, pp. 1036 - 1043
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2011, Volume 70, Issue 3, pp. 488 - 494
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1178 - 1182
Objectives The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil... 
MAINTENANCE | Cyclophosphamide | Treatment | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | Granulomatosis with polyangiitis | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | B cells | RHEUMATOLOGY | Systemic vasculitis | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Renal Insufficiency, Chronic - etiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Female | Microscopic Polyangiitis - immunology | Drug Therapy, Combination | B-Lymphocytes - cytology | Renal Insufficiency, Chronic - immunology | Rituximab | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Disease Progression | Disease-Free Survival | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Lymphocyte Count | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Granulomatosis with Polyangiitis - complications | Kidney Failure, Chronic - etiology | Usage | Care and treatment | Vasculitis | Patient outcomes | Clinical trials | Dosage and administration | Comparative analysis | Risk factors | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | B cells; Cyclophosphamide; Granulomatosis with polyangiitis; Systemic vasculitis; Treatment | Medicin och hälsovetenskap
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2013, Volume 74, Issue 1, pp. 177 - 184
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2017, Volume 76, Issue 10, pp. 1662 - 1668
ObjectivesA prospective randomised trial to compare two different durations of maintenance immunosuppressive therapy for the prevention of relapse in... 
RELAPSE | ANTIBODY-ASSOCIATED VASCULITIS | RISK-FACTORS | AZATHIOPRINE | PROTEINASE-3 | SYSTEMIC VASCULITIDES | INDUCTION | RHEUMATOLOGY | MAINTENANCE THERAPY | DAMAGE | RENAL SURVIVAL | Prednisolone - adverse effects | Azathioprine - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Male | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - blood | Secondary Prevention - methods | Cyclophosphamide - therapeutic use | Maintenance Chemotherapy - adverse effects | Anti-Inflammatory Agents - adverse effects | Maintenance Chemotherapy - methods | Time Factors | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Glomerular Filtration Rate | Survival Rate | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Kidney Failure, Chronic - blood | Creatinine - blood | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Antibodies, Antineutrophil Cytoplasmic - blood | Kidney Failure, Chronic - etiology | Prevention | Complications and side effects | Autoantibodies | Vasculitis | Dosage and administration | Diagnosis | Risk factors | Creatinine | End-stage renal disease | Renal function | Rheumatology | Neutrophils | Antibodies | Arthritis | Survival | Immunosuppressive agents | Cyclophosphamide | Medical prognosis | Antineutrophil cytoplasmic antibodies | Remission | Kidney diseases | Azathioprine | Drug dosages | Prednisolone | Kidney transplantation | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Reumatologi och inflammation
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2012, Volume 41, Issue 6, pp. 859 - 865
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2014, Volume 73, Issue 10, pp. 1854 - 1863
Journal Article